Contineum Therapeutics Ratios (2023-2025) | CTNM

Ratios Mar2023 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 5,243.48%-36,465.52%
EBIT Margin 5,559.78%-33,566.38%
EBITDA Margin 5,170.65%-35,782.76%
Operating Margin 5,559.78%-33,566.38%
Net Margin 5,243.48%-35,837.07%
FCF Margin 5,756.52%-35,037.07%
Efficiency
Assets Average 126.97M172.46M218.69M214.44M205.56M190.58M186.87M
Equity Average -71.78M70.94M213.87M204.15M191.42M178.08M175.93M
Invested Capital -67.94M-75.63M217.50M210.23M198.07M184.77M171.39M180.47M
Leverage & Solvency
Interest Coverage Ratio -55.60335.66
Equity Ratio -0.52-0.610.980.970.930.930.940.95
Times Interest Earned -55.60335.66
Valuation
Enterprise Value -125.19M-117.91M234.33M278.43M172.88M-10.13M-72.77M147.09M
Market Capitalization 452.99M492.34M377.64M180.58M102.71M329.49M
Return Ratios
Return on Capital Employed 0.09%-0.23%-0.20%-0.25%
Return on Assets 0.15%-0.18%-0.16%-0.20%
Return on Equity -0.27%-0.44%-0.17%-0.21%